 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
3 terms
|
 |
|
Biochemical function
|
protein binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
268:460-467
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10.
|
|
A.Zdanov,
C.Schalk-Hihi,
S.Menon,
K.W.Moore,
A.Wlodawer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of Epstein-Barr virus protein BCRF1, an analog of cellular
interleukin-10 (IL-10), has been determined at the resolution of 1.9 A and
refined to an R-factor 0.191. The structure of this cytokine is similar to that
of human IL-10 (hIL-10), forming an intercalated dimer of two 17 kDa
polypeptides related by a crystallographic 2-fold symmetry axis. BCRF1 exhibits
novel conformations of the N-terminal coil and of the loop between helices A and
B compared to hIL-10. These regions are likely to be involved in binding of one
or more components of the IL-10 receptor system, and thus the structural
differences may account for the lower binding affinity and limited spectrum of
biological activities of viral IL-10, compared to hIL-10.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. The alignment of amino acid sequences of viral
and human IL-10. Identical residues are shown in red, similar
residues in blue.
|
 |
Figure 4.
Figure 4. A putative receptor binding site in IL-10. Here
vIL-10 is shown in blue, hIL-10 in white, the hydrophobic patch
residues are in green, and polar residues in orange.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1997,
268,
460-467)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.E.Serrano,
E.Menares-Castillo,
M.Garrido-Tapia,
C.H.Ribeiro,
C.J.Hernández,
A.Mendoza-Naranjo,
M.Gatica-Andrades,
R.Valenzuela-Diaz,
R.Zúñiga,
M.N.López,
F.Salazar-Onfray,
J.C.Aguillón,
and
M.C.Molina
(2011).
Interleukin 10 decreases MICA expression on melanoma cell surface.
|
| |
Immunol Cell Biol, 89,
447-457.
|
 |
|
|
|
|
 |
Y.Chao,
Y.Jing,
Y.Jia,
Y.Wang,
C.Zhao,
and
B.Luo
(2011).
Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas.
|
| |
J Med Virol, 83,
644-650.
|
 |
|
|
|
|
 |
A.Zdanov
(2010).
Structural analysis of cytokines comprising the IL-10 family.
|
| |
Cytokine Growth Factor Rev, 21,
325-330.
|
 |
|
|
|
|
 |
R.Sabat,
G.Grütz,
K.Warszawska,
S.Kirsch,
E.Witte,
K.Wolk,
and
J.Geginat
(2010).
Biology of interleukin-10.
|
| |
Cytokine Growth Factor Rev, 21,
331-344.
|
 |
|
|
|
|
 |
B.Slobedman,
P.A.Barry,
J.V.Spencer,
S.Avdic,
and
A.Abendroth
(2009).
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.
|
| |
J Virol, 83,
9618-9629.
|
 |
|
|
|
|
 |
L.Bortesi,
M.Rossato,
F.Schuster,
N.Raven,
J.Stadlmann,
L.Avesani,
A.Falorni,
F.Bazzoni,
R.Bock,
S.Schillberg,
and
M.Pezzotti
(2009).
Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco.
|
| |
BMC Biotechnol, 9,
22.
|
 |
|
|
|
|
 |
A.Pietrzak,
A.Zalewska,
G.Chodorowska,
P.Nockowski,
A.Michalak-Stoma,
P.Osemlak,
and
D.Krasowska
(2008).
Genes and structure of selected cytokines involved in pathogenesis of psoriasis.
|
| |
Folia Histochem Cytobiol, 46,
11-21.
|
 |
|
|
|
|
 |
P.Van de Perre,
M.Segondy,
V.Foulongne,
A.Ouedraogo,
I.Konate,
J.M.Huraux,
P.Mayaud,
and
N.Nagot
(2008).
Herpes simplex virus and HIV-1: deciphering viral synergy.
|
| |
Lancet Infect Dis, 8,
490-497.
|
 |
|
|
|
|
 |
K.Kanai,
Y.Satoh,
H.Yamanaka,
A.Kawaguchi,
K.Horie,
K.Sugata,
Y.Hoshikawa,
T.Sata,
and
T.Sairenji
(2007).
The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.
|
| |
Virus Genes, 35,
563-569.
|
 |
|
|
|
|
 |
S.I.Yoon,
and
M.R.Walter
(2007).
Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli.
|
| |
Protein Expr Purif, 53,
132-137.
|
 |
|
|
|
|
 |
S.I.Yoon,
B.C.Jones,
N.J.Logsdon,
and
M.R.Walter
(2005).
Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.
|
| |
Structure, 13,
551-564.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Pestka,
C.D.Krause,
D.Sarkar,
M.R.Walter,
Y.Shi,
and
P.B.Fisher
(2004).
Interleukin-10 and related cytokines and receptors.
|
| |
Annu Rev Immunol, 22,
929-979.
|
 |
|
|
|
|
 |
C.Chang,
E.Magracheva,
S.Kozlov,
S.Fong,
G.Tobin,
S.Kotenko,
A.Wlodawer,
and
A.Zdanov
(2003).
Crystal structure of interleukin-19 defines a new subfamily of helical cytokines.
|
| |
J Biol Chem, 278,
3308-3313.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Savan,
D.Igawa,
and
M.Sakai
(2003).
Cloning, characterization and expression analysis of interleukin-10 from the common carp, Cyprinus carpio L.
|
| |
Eur J Biochem, 270,
4647-4654.
|
 |
|
|
|
|
 |
B.C.Jones,
N.J.Logsdon,
K.Josephson,
J.Cook,
P.A.Barry,
and
M.R.Walter
(2002).
Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1.
|
| |
Proc Natl Acad Sci U S A, 99,
9404-9409.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Fickenscher,
S.Hör,
H.Küpers,
A.Knappe,
S.Wittmann,
and
H.Sticht
(2002).
The interleukin-10 family of cytokines.
|
| |
Trends Immunol, 23,
89-96.
|
 |
|
|
|
|
 |
K.Vandenbroeck,
I.Alloza,
D.Brehmer,
A.Billiau,
P.Proost,
N.McFerran,
S.Rüdiger,
and
B.Walker
(2002).
The conserved helix C region in the superfamily of interferon-gamma /interleukin-10-related cytokines corresponds to a high-affinity binding site for the HSP70 chaperone DnaK.
|
| |
J Biol Chem, 277,
25668-25676.
|
 |
|
|
|
|
 |
B.E.Gewurz,
R.Gaudet,
D.Tortorella,
E.W.Wang,
and
H.L.Ploegh
(2001).
Virus subversion of immunity: a structural perspective.
|
| |
Curr Opin Immunol, 13,
442-450.
|
 |
|
|
|
|
 |
K.W.Moore,
R.de Waal Malefyt,
R.L.Coffman,
and
A.O'Garra
(2001).
Interleukin-10 and the interleukin-10 receptor.
|
| |
Annu Rev Immunol, 19,
683-765.
|
 |
|
|
|
|
 |
A.Knappe,
S.Hör,
S.Wittmann,
and
H.Fickenscher
(2000).
Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.
|
| |
J Virol, 74,
3881-3887.
|
 |
|
|
|
|
 |
K.Asadullah,
W.D.Döcke,
R.V.Sabat,
H.D.Volk,
and
W.Sterry
(2000).
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
|
| |
Expert Opin Investig Drugs, 9,
95.
|
 |
|
|
|
|
 |
S.V.Kotenko,
S.Saccani,
L.S.Izotova,
O.V.Mirochnitchenko,
and
S.Pestka
(2000).
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).
|
| |
Proc Natl Acad Sci U S A, 97,
1695-1700.
|
 |
|
|
|
|
 |
Y.Ding,
L.Qin,
S.V.Kotenko,
S.Pestka,
and
J.S.Bromberg
(2000).
A single amino acid determines the immunostimulatory activity of interleukin 10.
|
| |
J Exp Med, 191,
213-224.
|
 |
|
|
|
|
 |
D.M.Hoover,
C.Schalk-Hihi,
C.C.Chou,
S.Menon,
A.Wlodawer,
and
A.Zdanov
(1999).
Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization.
|
| |
Eur J Biochem, 262,
134-141.
|
 |
|
|
|
|
 |
F.M.Brodsky
(1999).
Stealth, sabotage and exploitation.
|
| |
Immunol Rev, 168,
5.
|
 |
|
|
|
|
 |
H.L.Ploegh
(1998).
Viral strategies of immune evasion.
|
| |
Science, 280,
248-253.
|
 |
|
|
|
|
 |
J.M.Matthews,
A.Hammacher,
G.J.Howlett,
and
R.J.Simpson
(1998).
Physicochemical characterization of an antagonistic human interleukin-6 dimer.
|
| |
Biochemistry, 37,
10671-10680.
|
 |
|
|
|
|
 |
U.Reineke,
R.Sabat,
H.D.Volk,
and
J.Schneider-Mergener
(1998).
Mapping of the interleukin-10/interleukin-10 receptor combining site.
|
| |
Protein Sci, 7,
951-960.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|